EORTC – European Organisation for Research and Treatment of Cancer shared a post on LinkedIn:
“Just published!
Our latest analysis from the EORTC-1219/DAHANCA-29 trial shows how prospective individual case reviews (p-ICR) can significantly improve radiotherapy planning quality in head and neck cancer.
p-ICR boosted delineation accuracy and protocol compliance across centers.
Dose planning remained consistently high throughout.
This reinforces the value of tailored QA strategies in complex treatments.
Proud to contribute to advancing radiotherapy standards in clinical trials.
Read the full publication.”
Title: Radiotherapy quality assurance of the prospective randomised EORTC-1219/DAHANCA-29 trial: an individual case review analysis
Authors: Najlaa Alyamani, André Abrunhosa-Branquinho, Coreen Corning, Marjan Sharabiani, Pierre Castadot, Jordi Giralt, Joanna Kazmierska, Warren Grant, Melissa Christiaens, Milan Tomsej, Raquel Bar-Deroma, Angelo F. Monti, Jean-Jacques Stelmes, Enrico Clementel, Catherine Fortpied, Sandra Collette, Coen W. Hurkmans, Vincent Grégoire, Jens Overgaard, D.-C. Weber, Nicolaus Andratschke
More posts featuring EORTC on OncoDaily.